Jay A. Levy, M.D. - Publications

Medicine University of California, San Francisco, San Francisco, CA 
Retroviruses, AIDS, HIV, Oncoviruses

367 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Morvan MG, Teque FC, Locher CP, Levy JA. The CD8 T Cell Noncytotoxic Antiviral Responses. Microbiology and Molecular Biology Reviews : Mmbr. 85. PMID 33980586 DOI: 10.1128/MMBR.00155-20  0.441
2021 Morvan MG, Teque F, Ye L, Moreno ME, Wang J, VandenBerg S, Stoddart CA, Kan YW, Levy JA. Genetically edited CD34 cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33975958 DOI: 10.1073/pnas.2102404118  0.35
2020 Levy JA. The need to reassess our approaches at HIV cure and prevention. Aids (London, England). PMID 32991381 DOI: 10.1097/QAD.0000000000002695  0.33
2020 Ye L, Wang J, Teque F, Xie F, Tan Y, Kan YW, Levy JA. Generation of HIV-1-infected patients' gene-edited induced pluripotent stem cells using feeder-free culture conditions. Aids (London, England). 34: 1127-1139. PMID 32501846 DOI: 10.1097/Qad.0000000000002535  0.389
2020 Teque F, Ye L, Xie F, Wang J, Morvan MG, Kan YW, Levy JA. Genetically-edited iPSCs derived from HIV-1 infected patients on therapy can give rise to immune cells resistant to HIV-1 infection. Aids (London, England). PMID 32287059 DOI: 10.1097/Qad.0000000000002539  0.518
2020 Ye L, Wang J, Teque F, Xie F, Tan Y, Kan YW, Levy JA. Generation of HIV-1 infected patient's gene-edited iPSC using feeder free culture conditions. Aids (London, England). PMID 32287058 DOI: 10.1097/QAD.0000000000002535  0.374
2018 Hecht FM, Moskowitz JT, Moran P, Epel ES, Bacchetti P, Acree M, Kemeny ME, Mendes WB, Duncan LG, Weng H, Levy JA, Deeks SG, Folkman S. A Randomized, Controlled Trial of Mindfulness-Based Stress Reduction in HIV Infection. Brain, Behavior, and Immunity. PMID 29842903 DOI: 10.1016/J.Bbi.2018.05.017  0.417
2017 Levy JA. Abstract IA36: HIV, HTLV, and EBV infection and the development of cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Newfront17-Ia36  0.566
2015 Blazek D, Teque F, Mackewicz C, Peterlin M, Levy JA. The CD8+ cell noncytotoxic antiviral response (CNAR) affects RNA Polymerase II-mediated HIV transcription in infected CD4+ cells. The Journal of General Virology. PMID 26499373 DOI: 10.1099/Jgv.0.000326  0.532
2015 Levy JA. Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor. Proceedings of the National Academy of Sciences of the United States of America. PMID 26085138 DOI: 10.1073/Pnas.1509324112  0.552
2015 Levy JA. Dispelling myths and focusing on notable concepts in HIV pathogenesis. Trends in Molecular Medicine. 21: 341-353. PMID 25883070 DOI: 10.1016/J.Molmed.2015.03.004  0.487
2015 Roff SR, Sanou MP, Rathore MH, Levy JA, Yamamoto JK. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects. Human Vaccines & Immunotherapeutics. 11: 1540-56. PMID 25844718 DOI: 10.1080/21645515.2015.1026500  0.49
2014 Ye L, Wang J, Beyer AI, Teque F, Cradick TJ, Qi Z, Chang JC, Bao G, Muench MO, Yu J, Levy JA, Kan YW. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection. Proceedings of the National Academy of Sciences of the United States of America. 111: 9591-6. PMID 24927590 DOI: 10.1073/Pnas.1407473111  0.447
2014 Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits. Clinical and Vaccine Immunology : Cvi. 21: 1086-93. PMID 24872518 DOI: 10.1128/Cvi.00320-14  0.338
2013 Sanou MP, Roff SR, Mennella A, Sleasman JW, Rathore MH, Yamamoto JK, Levy JA. Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects. Journal of Virology. 87: 10004-15. PMID 23824804 DOI: 10.1128/Jvi.00359-13  0.493
2013 Liu L, Wang L, Huang L, Siu V, Teque F, Aweeka FT, Levy JA. Nevirapine inhibits the anti-HIV activity of CD8+ cells. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 184-8. PMID 23392464 DOI: 10.1097/Qai.0B013E318289822D  0.494
2013 Ippolito G, Levy JA, Sonnerborg A, Mugusi F, Dianzani F. AIDS and HIV Infection after Thirty Years. Aids Research and Treatment. 2013: 731983. PMID 23365727 DOI: 10.1155/2013/731983  0.51
2013 Kaushik S, Teque F, Patel M, Fujimura SH, Schmidt B, Levy JA. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state. Aids Research and Human Retroviruses. 29: 501-10. PMID 23131038 DOI: 10.1089/Aid.2012.0200  0.455
2013 Araya AX, Norr KF, Pérez CM, Levy JA, Park CG, Kim MJ. HIV-related symptoms and patient clusters among Chileans living with HIV. Aids Care. 25: 488-95. PMID 22909386 DOI: 10.1080/09540121.2012.714457  0.346
2012 Sanou MP, De Groot AS, Murphey-Corb M, Levy JA, Yamamoto JK. HIV-1 Vaccine Trials: Evolving Concepts and Designs. The Open Aids Journal. 6: 274-88. PMID 23289052 DOI: 10.2174/1874613601206010274  0.418
2012 Levy JA, Levy Y. HIV infection: what should be considered in approaches for a cure? Aids (London, England). 26: 2253-5. PMID 23060292 DOI: 10.1097/Qad.0B013E32835Ac83A  0.534
2012 Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. Journal of Virology. 86: 2556-70. PMID 22205732 DOI: 10.1128/Jvi.06578-11  0.5
2011 Killian MS, Levy JA. HIV/AIDS: 30 years of progress and future challenges. European Journal of Immunology. 41: 3401-11. PMID 22125008 DOI: 10.1002/Eji.201142082  0.549
2011 Liu L, Johnson C, Fujimura S, Teque F, Levy JA. Transfection optimization for primary human CD8+ cells. Journal of Immunological Methods. 372: 22-9. PMID 21777592 DOI: 10.1016/J.Jim.2011.06.026  0.394
2011 Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, Hackett J, Qiu X, Luk KC, Schochetman G, Knox A, Kogelnik AM, Levy JA. No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science (New York, N.Y.). 333: 94-7. PMID 21628393 DOI: 10.1126/Science.1204963  0.383
2011 Levy JA. Virus-host interactions in HIV pathogenesis: directions for therapy. Advances in Dental Research. 23: 13-8. PMID 21441474 DOI: 10.1177/0022034511398874  0.531
2011 Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, et al. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. The Journal of Infectious Diseases. 203: 442-51. PMID 21245157 DOI: 10.1093/Infdis/Jiq085  0.49
2011 Killian MS, Johnson C, Teque F, Fujimura S, Levy JA. Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells. Journal of Virology. 85: 1696-705. PMID 21147929 DOI: 10.1128/Jvi.01120-10  0.487
2011 Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology. 409: 211-22. PMID 21056450 DOI: 10.1016/J.Virol.2010.10.004  0.474
2011 Levy JA, Phair JP, Daly PJ. AIDS: Editorial update Aids. 25: 547-548. DOI: 10.1097/Qad.0B013E3283430Aa5  0.335
2010 Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, ... ... Levy JA, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (New York, N.Y.). 330: 1551-7. PMID 21051598 DOI: 10.1126/Science.1195271  0.383
2010 Ndhlovu LC, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Eccles-James I, Tincati C, Levy JA, Nixon DF, Hecht FM, Barbour JD. IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. Journal of Clinical Immunology. 30: 681-92. PMID 20571894 DOI: 10.1007/S10875-010-9432-3  0.401
2009 Yuan L, Ma L, Fan X, Feng Y, Peng H, Zhao Q, Ruan Y, Levy JA, Shao Y. CD8+ cell noncytotoxic antiviral response in long-term HIV-1 infected former blood donors in China. Current Hiv Research. 7: 437-40. PMID 19601780 DOI: 10.2174/157016209788680561  0.441
2009 Levy JA. Not an HIV cure, but encouraging new directions. The New England Journal of Medicine. 360: 724-5. PMID 19213687 DOI: 10.1056/Nejme0810248  0.422
2009 Barbour JD, Ndhlovu LC, Xuan Tan Q, Ho T, Epling L, Bredt BM, Levy JA, Hecht FM, Sinclair E. High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. Plos One. 4: e4408. PMID 19198651 DOI: 10.1371/Journal.Pone.0004408  0.48
2009 Killian MS, Roop J, Ng S, Hecht FM, Levy JA. CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy. Journal of Clinical Immunology. 29: 311-8. PMID 19189205 DOI: 10.1007/S10875-009-9275-Y  0.507
2009 Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. Aids (London, England). 23: 147-60. PMID 19098484 DOI: 10.1097/Qad.0B013E3283217F9F  0.424
2009 Ndhlovu L, Sinclair E, Epling L, Tan QX, Ho T, Jha AR, Levy JA, Nixon DF, Barbour JD, Hecht FM. P16-10. IL-2 therapy mediates expansion of Treg cells, maintains IL-17 expressing CD4+ T-cells and selectively suppresses HIV specific T-cell responses Retrovirology. 6: P239. DOI: 10.1186/1742-4690-6-S3-P239  0.372
2008 Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. The Journal of Clinical Investigation. 118: 1244-54. PMID 18382737 DOI: 10.1172/Jci34706  0.497
2008 Bonneau KR, Ng S, Foster H, Choi KB, Berkhout B, Rabson A, Mackewicz CE, Levy JA. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response. Virology. 373: 30-8. PMID 18086484 DOI: 10.1016/J.Virol.2007.11.003  0.536
2007 Sriram U, Wong M, Caillier SJ, Hecht FM, Elkins MK, Levy JA, Oksenberg JR, Baranzini SE. Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. Aids Research and Human Retroviruses. 23: 741-7. PMID 17531001 DOI: 10.1089/Aid.2007.0209  0.424
2007 Song H, Nakayama EE, Yokoyama M, Sato H, Levy JA, Shioda T. A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. Journal of Virology. 81: 7280-5. PMID 17475650 DOI: 10.1128/Jvi.00406-07  0.514
2007 Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, Oksenberg JR. Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. Plos Pathogens. 3: e43. PMID 17447840 DOI: 10.1371/Journal.Ppat.0030043  0.439
2007 Martinez-Mariño B, Foster H, Hao Y, Levy JA. Differential gene expression in CD8(+) cells from HIV-1-infected subjects showing suppression of HIV replication. Virology. 362: 217-25. PMID 17240414 DOI: 10.1016/J.Virol.2006.12.007  0.521
2007 Schmidt B, Kittan NA, Haupt S, Levy JA. Innate cellular immune responses in HIV infection The Biology of Dendritic Cells and Hiv Infection. 297-332. DOI: 10.1007/978-0-387-33785-2_8  0.361
2006 Killian MS, Norris PJ, Rawal BD, Lebedeva M, Hecht FM, Levy JA, Busch MP. The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. Aids Research and Human Retroviruses. 22: 640-7. PMID 16831088 DOI: 10.1089/Aid.2006.22.640  0.428
2006 Killian MS, Fujimura SH, Hecht FM, Levy JA. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. Aids (London, England). 20: 1247-52. PMID 16816552 DOI: 10.1097/01.Aids.0000232231.34253.Bd  0.502
2006 Levy JA. HIV pathogenesis: knowledge gained after two decades of research. Advances in Dental Research. 19: 10-6. PMID 16672543 DOI: 10.1177/154407370601900104  0.544
2006 Hare CB, Pappalardo BL, Busch MP, Karlsson AC, Phelps BH, Alexander SS, Bentsen C, Ramstead CA, Nixon DF, Levy JA, Hecht FM. Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 700-8. PMID 16447118 DOI: 10.1086/500215  0.525
2006 Schmidt B, Fujimura SH, Martin JN, Levy JA. Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy. Journal of Clinical Immunology. 26: 55-64. PMID 16418803 DOI: 10.1007/S10875-006-8401-3  0.467
2005 Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology. 343: 256-66. PMID 16278001 DOI: 10.1016/J.Virol.2005.09.059  0.548
2005 Lennette ET, Busch MP, Hecht FM, Levy JA. Potential herpesvirus interaction during HIV type 1 primary infection. Aids Research and Human Retroviruses. 21: 869-75. PMID 16225414 DOI: 10.1089/Aid.2005.21.869  0.552
2005 Killian MS, Ng S, Mackewicz CE, Levy JA. A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses. Journal of Immunological Methods. 304: 137-50. PMID 16129447 DOI: 10.1016/J.Jim.2005.07.016  0.487
2005 Hasnain M, Sinacore JM, Mensah EK, Levy JA. Influence of religiosity on HIV risk behaviors in active injection drug users. Aids Care. 17: 892-901. PMID 16120505 DOI: 10.1080/09540120500038280  0.304
2005 Locher CP, Witt SA, Kassel R, Dowell NL, Fujimura S, Levy JA. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation. The Journal of General Virology. 86: 1171-9. PMID 15784911 DOI: 10.1099/Vir.0.80674-0  0.451
2005 Diaz LS, Foster H, Stone MR, Fujimura S, Relman DA, Levy JA. VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity. Journal of Immunology (Baltimore, Md. : 1950). 174: 1574-9. PMID 15661918 DOI: 10.4049/Jimmunol.174.3.1574  0.451
2005 Elkins MK, Vittinghoff E, Baranzini SE, Hecht FM, Sriram U, Busch MP, Levy JA, Oksenberg JR. Longitudinal analysis of B cell repertoire and antibody gene rearrangements during early HIV infection. Genes and Immunity. 6: 66-9. PMID 15538390 DOI: 10.1038/Sj.Gene.6364146  0.485
2004 Ward EG, Disch WB, Levy JA, Schensul JJ. Perception of HIV/AIDS risk among urban, low-income senior-housing residents. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 16: 571-88. PMID 15585432 DOI: 10.1521/Aeap.16.6.571.53795  0.323
2004 Martinez-Mariño B, Shiboski S, Hecht FM, Kahn JO, Levy JA. Interleukin-2 therapy restores CD8 cell non-cytotoxic anti-HIV responses in primary infection subjects receiving HAART. Aids (London, England). 18: 1991-9. PMID 15577620 DOI: 10.1097/00002030-200410210-00003  0.452
2004 Schmidt B, Scott I, Whitmore RG, Foster H, Fujimura S, Schmitz J, Levy JA. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology. 329: 280-8. PMID 15518808 DOI: 10.1016/J.Virol.2004.08.016  0.567
2004 Schmidt B, Ashlock B, Neipel F, Levy JA. Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production. Journal of Clinical Microbiology. 42: 4300-2. PMID 15365027 DOI: 10.1128/Jcm.42.9.4300-4302.2004  0.403
2004 Levy JA, Autran B, Coutinho R, Phair JP. Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase. Aids (London, England). 18: 1087. PMID 15166523 DOI: 10.1097/00002030-200405210-00001  0.387
2004 Locher CP, Witt SA, Ashlock BM, Polacino P, Hu SL, Shiboski S, Schmidt AM, Agy MB, Anderson DM, Staprans SI, zur Megede J, Levy JA. Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection. Vaccine. 22: 2261-72. PMID 15149785 DOI: 10.1016/J.Vaccine.2003.11.045  0.458
2004 Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 104: 942-7. PMID 15117761 DOI: 10.1182/Blood-2003-09-3333  0.483
2004 Martinez-Mariño B, Ashlock BM, Shiboski S, Hecht FM, Levy JA. Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection. Journal of Clinical Immunology. 24: 135-44. PMID 15024180 DOI: 10.1023/B:Joci.0000019778.96564.26  0.497
2004 Locher CP, Witt SA, Ashlock BM, Levy JA. Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine. Dna and Cell Biology. 23: 107-10. PMID 15000750 DOI: 10.1089/104454904322759911  0.443
2004 Castelli J, Thomas EK, Gilliet M, Liu YJ, Levy JA. Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15. Blood. 103: 2699-704. PMID 14684414 DOI: 10.1182/Blood-2003-06-1913  0.423
2003 Locher CP, Putnam D, Langer R, Witt SA, Ashlock BM, Levy JA. Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulation. Immunology Letters. 90: 67-70. PMID 14687705 DOI: 10.1016/J.Imlet.2003.02.001  0.357
2003 Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, Allen TM, Feeney ME, Kahn JO, Sekaly RP, Levy JA, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. Aids (London, England). 17: 2581-91. PMID 14685052 DOI: 10.1097/00002030-200312050-00005  0.503
2003 Levy JA. The search for the CD8+ cell anti-HIV factor (CAF). Trends in Immunology. 24: 628-32. PMID 14644135 DOI: 10.1016/J.It.2003.10.005  0.528
2003 Li JZ, Mack EC, Levy JA. Virucidal efficacy of soap and water against human immunodeficiency virus in genital secretions. Antimicrobial Agents and Chemotherapy. 47: 3321-2. PMID 14506048 DOI: 10.1128/Aac.47.10.3321-3322.2003  0.525
2003 Mackewicz CE, Yuan J, Tran P, Diaz L, Mack E, Selsted ME, Levy JA. alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. Aids (London, England). 17: F23-32. PMID 14502030 DOI: 10.1097/00002030-200309260-00001  0.5
2003 Levy JA, Scott I, Mackewicz C. Protection from HIV/AIDS: the importance of innate immunity. Clinical Immunology (Orlando, Fla.). 108: 167-74. PMID 14499239 DOI: 10.1016/S1521-6616(03)00178-5  0.439
2003 Levy JA, Ory MG, Crystal S. HIV/AIDS interventions for midlife and older adults: current status and challenges. Journal of Acquired Immune Deficiency Syndromes (1999). 33: S59-67. PMID 12853854 DOI: 10.1097/00126334-200306012-00002  0.322
2003 Diaz LS, Stone MR, Mackewicz CE, Levy JA. Differential gene expression in CD8+ cells exhibiting noncytotoxic anti-HIV activity. Virology. 311: 400-9. PMID 12842629 DOI: 10.1016/S0042-6822(03)00177-6  0.443
2003 Mackewicz CE, Wang B, Metkar S, Richey M, Froelich CJ, Levy JA. Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules. Blood. 102: 180-3. PMID 12649153 DOI: 10.1182/Blood-2002-10-3034  0.465
2003 Mackewicz CE, Craik CS, Levy JA. The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 100: 3433-8. PMID 12624186 DOI: 10.1073/Pnas.0630379100  0.426
2003 Locher CP, Fujimura S, Murthy KK, Brasky K, Leland M, Levy JA. Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboons. Aids Research and Human Retroviruses. 19: 31-40. PMID 12581514 DOI: 10.1089/08892220360473943  0.503
2003 Levy JA. Is HIV superinfection worrisome? Lancet. 361: 98-9. PMID 12531573 DOI: 10.1016/S0140-6736(03)12242-8  0.482
2003 Locher CP, Witt SA, Herndier BG, Abbey NW, Tenner-Racz K, Racz P, Kiviat NB, Murthy KK, Brasky K, Leland M, Levy JA. Increased virus replication and virulence after serial passage of human immunodeficiency virus type 2 in baboons. Journal of Virology. 77: 77-83. PMID 12477812 DOI: 10.1128/Jvi.77.1.77-83.2003  0.569
2002 Soumelis V, Scott I, Liu Y, Levy J. Natural type 1 interferon producing cells in HIV infection. Human Immunology. 63: 1206-1212. PMID 12480265 DOI: 10.1016/S0198-8859(02)00760-7  0.55
2002 Locher CP, Witt SA, Ashlock BM, Levy JA. Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element. Dna and Cell Biology. 21: 581-6. PMID 12215261 DOI: 10.1089/104454902320308951  0.357
2002 Levy JA. HIV-1: hitching a ride on erythrocytes. Lancet. 359: 2212-3. PMID 12103280 DOI: 10.1016/S0140-6736(02)09314-5  0.471
2002 Castelli JC, Deeks SG, Shiboski S, Levy JA. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood. 99: 4225-7. PMID 12010831 DOI: 10.1182/Blood-2001-11-0078  0.502
2002 Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. Aids (London, England). 16: 1119-29. PMID 12004270 DOI: 10.1097/00002030-200205240-00005  0.471
2001 Locher CP, Witt SA, Herndier BG, Tenner-Racz K, Racz P, Levy JA. Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development. Immunological Reviews. 183: 127-40. PMID 11782253 DOI: 10.1034/J.1600-065X.2001.1830111.X  0.558
2001 Locher CP, Witt SA, Levy JA. The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytes. Aids (London, England). 15: 2455-7. PMID 11774833 DOI: 10.1097/00002030-200112070-00016  0.364
2001 Ghanekar SA, Stranford SA, Ong JC, Walker JM, Maino VC, Levy JA. Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy. Aids (London, England). 15: 1885-7. PMID 11579254 DOI: 10.1097/00002030-200109280-00021  0.51
2001 Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L, Huang L, Levy JA, Liu YJ. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood. 98: 906-12. PMID 11493432 DOI: 10.1182/Blood.V98.4.906  0.524
2001 Levy JA. The importance of the innate immune system in controlling HIV infection and disease. Trends in Immunology. 22: 312-6. PMID 11377290 DOI: 10.1016/S1471-4906(01)01925-1  0.402
2001 Levy JA. What can be achieved with an HIV vaccine? Lancet. 357: 223-4. PMID 11213112 DOI: 10.1016/S0140-6736(00)03601-1  0.389
2001 Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, ... Levy JA, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. The Journal of Experimental Medicine. 193: 169-80. PMID 11148221 DOI: 10.1084/Jem.193.2.169  0.49
2001 Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proceedings of the National Academy of Sciences of the United States of America. 98: 597-602. PMID 11136234 DOI: 10.1073/Pnas.98.2.597  0.517
2001 Schito AM, Vittinghoff E, Hecht FM, Elkins MK, Kahn JO, Levy JA, Oksenberg JR. Longitudinal analysis of T-cell receptor gene use by CD8(+) T cells in early human immunodeficiency virus infection in patients receiving highly active antiretroviral therapy. Blood. 97: 214-20. PMID 11133763 DOI: 10.1182/Blood.V97.1.214  0.421
2000 Kliks S, Contag CH, Corliss H, Learn G, Rodrigo A, Wara D, Mullins JI, Levy JA. Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns. Aids Research and Human Retroviruses. 16: 1223-33. PMID 10957720 DOI: 10.1089/08892220050116998  0.378
2000 Blackbourn DJ, Lennette E, Klencke B, Moses A, Chandran B, Weinstein M, Glogau RG, Witte MH, Way DL, Kutzkey T, Herndier B, Levy JA. The restricted cellular host range of human herpesvirus 8. Aids (London, England). 14: 1123-33. PMID 10894276 DOI: 10.1097/00002030-200006160-00009  0.364
2000 Mackewicz CE, Patterson BK, Lee SA, Levy JA. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. The Journal of General Virology. 81: 1261-4. PMID 10769068 DOI: 10.1099/0022-1317-81-5-1261  0.532
2000 Mackewicz CE, Ridha S, Levy JA. HIV virions and HIV replication are unaffected by granulysin. Aids (London, England). 14: 328-30. PMID 10716513 DOI: 10.1097/00002030-200002180-00019  0.489
2000 Mackewicz CE, Lieberman J, Froelich C, Levy JA. HIV virions and HIV infection in vitro are unaffected by human granzymes A and B. Aids Research and Human Retroviruses. 16: 367-72. PMID 10716374 DOI: 10.1089/088922200309241  0.528
2000 Mackewicz CE, Ridha S, Levy JA. Fas and Fas ligand are not involved in the suppression of HIV replication by CD8 cells. Aids (London, England). 14: 204-5. PMID 10708293 DOI: 10.1097/00002030-200001280-00018  0.469
2000 Levy JA, Phair JP, Laga M. To the AIDS readership Aids. 14: 1479. DOI: 10.1097/00002030-200007280-00002  0.357
1999 Locher CP, Grant RM, Collisson EA, Reyes-Terán G, Elbeik T, Kahn JO, Levy JA. Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination. Aids Research and Human Retroviruses. 15: 1685-9. PMID 10606091 DOI: 10.1089/088922299309720  0.555
1999 Mourich DV, Lee S, Reyes-Teran G, Mackewicz CE, Levy JA. Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease. Aids Research and Human Retroviruses. 15: 1573-5. PMID 10580408 DOI: 10.1089/088922299309865  0.449
1999 Barker E, Bossart KN, Fujimura SH, Levy JA. The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication. Cellular Immunology. 196: 95-103. PMID 10527561 DOI: 10.1006/Cimm.1999.1551  0.366
1999 Greco G, Mackewicz C, Levy JA. Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines. The Journal of General Virology. 80: 2369-73. PMID 10501489 DOI: 10.1099/0022-1317-80-9-2369  0.525
1999 Locher CP, Blackbourn DJ, Levy JA. Suppression of human immunodeficiency virus type 1 replication by a soluble factor produced by CD8+ lymphocytes from HIV-2-infected baboons. Immunology Letters. 66: 151-7. PMID 10203048 DOI: 10.1016/S0165-2478(98)00175-8  0.57
1999 Stranford SA, Skurnick J, Louria D, Osmond D, Chang SY, Sninsky J, Ferrari G, Weinhold K, Lindquist C, Levy JA. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proceedings of the National Academy of Sciences of the United States of America. 96: 1030-5. PMID 9927688 DOI: 10.1073/Pnas.96.3.1030  0.548
1999 Levy JA. Xenotropism: the elusive viral receptor finally uncovered. Proceedings of the National Academy of Sciences of the United States of America. 96: 802-4. PMID 9927648 DOI: 10.1073/Pnas.96.3.802  0.412
1999 Greco G, Fujimura SH, Mourich DV, Levy JA. Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation. Journal of Virology. 73: 1528-34. PMID 9882358 DOI: 10.1128/Jvi.73.2.1528-1534.1999  0.542
1999 Blackbourn DJ, Osmond D, Levy JA, Lennette ET. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. The Journal of Infectious Diseases. 179: 237-9. PMID 9841846 DOI: 10.1086/314570  0.32
1998 Barker E, Bossart KN, Levy JA. Differential effects of CD28 costimulation on HIV production by CD4+ cells. Journal of Immunology (Baltimore, Md. : 1950). 161: 6223-7. PMID 9834109  0.327
1998 Greco G, Barker E, Levy JA. Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production. Aids Research and Human Retroviruses. 14: 1407-11. PMID 9824318 DOI: 10.1089/Aid.1998.14.1407  0.503
1998 Mackewicz CE, Garovoy MR, Levy JA. HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication. Journal of Virology. 72: 10165-70. PMID 9811757 DOI: 10.1128/Jvi.72.12.10165-10170.1998  0.463
1998 Barker E, Mackewicz CE, Reyes-Terán G, Sato A, Stranford SA, Fujimura SH, Christopherson C, Chang SY, Levy JA. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood. 92: 3105-14. PMID 9787145 DOI: 10.1182/Blood.V92.9.3105.421K46_3105_3114  0.579
1998 Levy JA. Caution: should we be treating HIV infection early? Lancet. 352: 982-3. PMID 9752836 DOI: 10.1016/S0140-6736(98)05391-4  0.494
1998 Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Buttò S, Lodi G, Di Carlo A, Levy JA, Ensoli B. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. International Journal of Cancer. Journal International Du Cancer. 77: 361-5. PMID 9663596 DOI: 10.1002/(Sici)1097-0215(19980729)77:3<361::Aid-Ijc9>3.0.Co;2-M  0.425
1998 Barker E, Kahn J, Fujimura S, Levy JA. Protease inhibitors do not increase the CD4+ cell count in HIV-uninfected individuals. Aids (London, England). 12: 1117-8. PMID 9662217  0.359
1998 Peersman GV, Levy JA. Focus and effectiveness of HIV-prevention efforts for young people. Aids (London, England). 12: S191-6. PMID 9633003  0.334
1998 Locher CP, Barnett SW, Herndier BG, Blackbourn DJ, Reyes-Terán G, Murthy KK, Brasky KM, Hubbard GB, Reinhart TA, Haase AT, Levy JA. Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. Archives of Pathology & Laboratory Medicine. 122: 523-33. PMID 9625420  0.407
1998 Renne R, Blackbourn D, Whitby D, Levy J, Ganem D. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. Journal of Virology. 72: 5182-8. PMID 9573290 DOI: 10.1128/Jvi.72.6.5182-5188.1998  0.435
1998 Levy JA, Hsueh F, Blackbourn DJ, Wara D, Weintrub PS. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. The Journal of Infectious Diseases. 177: 470-2. PMID 9466540 DOI: 10.1086/517378  0.545
1998 Barker E, Bossart KN, Levy JA. Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines. Proceedings of the National Academy of Sciences of the United States of America. 95: 1725-9. PMID 9465084 DOI: 10.1073/Pnas.95.4.1725  0.532
1998 Locher CP, Blackbourn DJ, Herndier BG, Reyes-Terán G, Barnett SW, Murthy KK, Levy JA. Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons. Aids Research and Human Retroviruses. 14: 79-82. PMID 9453254 DOI: 10.1089/Aid.1998.14.79  0.577
1998 Blackbourn DJ, Lennette ET, Ambroziak J, Mourich DV, Levy JA. Human herpesvirus 8 detection in nasal secretions and saliva. The Journal of Infectious Diseases. 177: 213-6. PMID 9419191 DOI: 10.1086/517356  0.367
1998 Blackbourn DJ, Mourich DV, Ricci G, Lennette ET, Levy JA. IDENTIFICATION OF CELLULAR AND VIRAL GENES POTENTIALLY INVOLVED IN HUMAN HERPESVIRUS (HHV)-8 PATHOGENESIS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A21. DOI: 10.1097/00042560-199804010-00055  0.329
1998 Levy JA. Early treatment of HIV-1 infection The Lancet. 352: 1936. DOI: 10.1016/S0140-6736(05)60432-1  0.475
1997 Locher CP, Blackbourn DJ, Barnett SW, Murthy KK, Cobb EK, Rouse S, Greco G, Reyes-Terán G, Brasky KM, Carey KD, Levy JA. Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response. The Journal of Infectious Diseases. 176: 948-59. PMID 9333153 DOI: 10.1086/516544  0.596
1997 Mackewicz CE, Barker E, Greco G, Reyes-Teran G, Levy JA. Do beta-chemokines have clinical relevance in HIV infection? The Journal of Clinical Investigation. 100: 921-30. PMID 9259592 DOI: 10.1172/Jci119608  0.538
1997 Levy JA. HIV neuropathogenesis. Journal of Neurovirology. 3: S14-5. PMID 9179783  0.367
1997 Blackbourn DJ, Locher CP, Ramachandran B, Barnett SW, Murthy KK, Carey KD, Brasky KM, Levy JA. CD8+ cells from HIV-2-infected baboons control HIV replication. Aids (London, England). 11: 737-46. PMID 9143605 DOI: 10.1097/00002030-199706000-00006  0.538
1997 Gulizia RJ, Collman RG, Levy JA, Trono D, Mosier DE. Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. Journal of Virology. 71: 4161-4. PMID 9094701 DOI: 10.1128/Jvi.71.5.4161-4164.1997  0.51
1997 Mackewicz CE, Orque R, Jung J, Levy JA. Derivation of herpesvirus saimiri-transformed CD8+ T cell lines with noncytotoxic anti-HIV activity. Clinical Immunology and Immunopathology. 82: 274-81. PMID 9073551 DOI: 10.1006/Clin.1996.4292  0.472
1997 Levy JA. Three new human herpesviruses (HHV6, 7, and 8). Lancet (London, England). 349: 558-63. PMID 9048803 DOI: 10.1016/S0140-6736(97)80119-5  0.405
1996 Barker E, Bossart KN, Locher CP, Patterson BK, Levy JA. CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. The Journal of General Virology. 77: 2953-62. PMID 9000085 DOI: 10.1099/0022-1317-77-12-2953  0.563
1996 Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunology Today. 17: 217-24. PMID 8991383 DOI: 10.1016/0167-5699(96)10011-6  0.54
1996 Mackewicz CE, Barker E, Levy JA. Role of beta-chemokines in suppressing HIV replication. Science (New York, N.Y.). 274: 1393-5. PMID 8966605 DOI: 10.1126/Science.274.5291.1393  0.425
1996 Blackbourn DJ, Mackewicz CE, Barker E, Hunt TK, Herndier B, Haase AT, Levy JA. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proceedings of the National Academy of Sciences of the United States of America. 93: 13125-30. PMID 8917555 DOI: 10.1073/Pnas.93.23.13125  0.523
1996 Locher CP, Blackbourn DJ, Castro BA, Brasky KM, Levy JA. Susceptibility of peripheral blood mononuclear cells from gorillas, orangutans and baboons to diverse HIV isolates. Aids (London, England). 10: 1438-40. PMID 8902080 DOI: 10.1097/00002030-199610000-00023  0.461
1996 Levy JA. The value of primate models for studying human immunodeficiency virus pathogenesis. Journal of Medical Primatology. 25: 163-74. PMID 8892037 DOI: 10.1111/J.1600-0684.1996.Tb00013.X  0.578
1996 Murthy KK, Cobb EK, el-Amad Z, Ortega H, Hsueh FC, Satterfield W, Lee DR, Kalish ML, Haigwood NL, Kennedy RC, Steimer KS, Schultz A, Levy JA. Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees. Aids Research and Human Retroviruses. 12: 1341-8. PMID 8891113 DOI: 10.1089/Aid.1996.12.1341  0.517
1996 Levy JA. Infection by human immunodeficiency virus--CD4 is not enough. The New England Journal of Medicine. 335: 1528-30. PMID 8890107 DOI: 10.1056/Nejm199611143352011  0.521
1996 Mackewicz CE, Levy JA, Cruikshank WW, Kornfeld H, Center DM. Role of IL-16 in HIV replication. Nature. 383: 488-9. PMID 8849720 DOI: 10.1038/383488A0  0.411
1996 Hartley CA, Gilbert MJ, Brigido L, Elbeik T, Levy JA, Crowe SM, Mills J. Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4. The Journal of General Virology. 77: 2015-23. PMID 8810998 DOI: 10.1099/0022-1317-77-9-2015  0.477
1996 Barnett SW, Legg HS, Sun Y, Klinger J, Blackbourn DJ, Locher CP, Levy JA. Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2UC2. Virology. 222: 257-61. PMID 8806506 DOI: 10.1006/Viro.1996.0417  0.529
1996 Voss TG, Fermin CD, Levy JA, Vigh S, Choi B, Garry RF. Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus. Journal of Virology. 70: 5447-54. PMID 8764056 DOI: 10.1128/Jvi.70.8.5447-5454.1996  0.521
1996 Levy JA. Surrogate markers in AIDS research. Is there truth in numbers? Jama. 276: 161-2. PMID 8656510 DOI: 10.1001/Jama.1996.03540020083035  0.472
1996 Gulizia RJ, Levy JA, Mosier DE. The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. Journal of Virology. 70: 4184-7. PMID 8648765 DOI: 10.1128/Jvi.70.6.4184-4187.1996  0.564
1996 Ffrench R, Stewart GJ, Penny R, Levy JA. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency. The Medical Journal of Australia. 164: 166-71. PMID 8628137  0.351
1996 Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chang Y, Moore P. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. The New England Journal of Medicine. 334: 1292-7. PMID 8609946 DOI: 10.1056/Nejm199605163342003  0.502
1996 Levy JA, Ramachandran B, Barker E, Guthrie J, Elbeik T. Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science (New York, N.Y.). 271: 670-1. PMID 8571134 DOI: 10.1126/Science.271.5249.670  0.464
1996 Ffrench R, Stewart GJ, Penny R, Levy JA. 3.2 How HIV produces immune deficiency The Medical Journal of Australia. 164: 166-171. DOI: 10.5694/J.1326-5377.1996.Tb122018.X  0.451
1996 Levy JA. Viral and immunological factors involved in HIV neuropathogenesis Journal of Neurovirology. 2: 7-7. DOI: 10.3109/13550289609146870  0.408
1996 Levy JA. Controversies: Does the CD4+ Cell Count Reflect Clinical Efficacy?-Reply Jama: the Journal of the American Medical Association. 276: 1219. DOI: 10.1001/Jama.1996.03540150021018  0.425
1995 el-Amad Z, Murthy KK, Higgins K, Cobb EK, Haigwood NL, Levy JA, Steimer KS. Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. Aids (London, England). 9: 1313-22. PMID 8605050 DOI: 10.1097/00002030-199512000-00003  0.479
1995 Sawai ET, Baur AS, Peterlin BM, Levy JA, Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. The Journal of Biological Chemistry. 270: 15307-14. PMID 7797518 DOI: 10.1074/jbc.270.25.15307  0.361
1995 Levy JA. HIV research: a need to focus on the right target. Lancet (London, England). 345: 1619-21. PMID 7783542 DOI: 10.1016/S0140-6736(95)90121-3  0.402
1995 Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (New York, N.Y.). 268: 582-3. PMID 7725108 DOI: 10.1126/Science.7725108  0.476
1995 Luciw PA, Pratt-Lowe E, Shaw KE, Levy JA, Cheng-Mayer C. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proceedings of the National Academy of Sciences of the United States of America. 92: 7490-4. PMID 7638218 DOI: 10.1073/Pnas.92.16.7490  0.579
1995 Tang S, Patterson B, Levy JA. Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation. Journal of Virology. 69: 5659-65. PMID 7637012 DOI: 10.1128/Jvi.69.9.5659-5665.1995  0.56
1995 Allan JS, Ray P, Broussard S, Whitehead E, Hubbard G, Butler T, Brasky K, Luciw P, Cheng-Mayer C, Levy JA. Infection of baboons with simian/human immunodeficiency viruses. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 9: 429-41. PMID 7627620 DOI: 10.1097/00042560-199508050-00001  0.547
1995 Ichimura H, Levy JA. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus. Virology. 211: 554-60. PMID 7544050 DOI: 10.1006/Viro.1995.1437  0.538
1995 Mackewicz CE, Blackbourn DJ, Levy JA. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences of the United States of America. 92: 2308-12. PMID 7534418 DOI: 10.1073/Pnas.92.6.2308  0.551
1995 Barker E, Mackewicz CE, Levy JA. Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proceedings of the National Academy of Sciences of the United States of America. 92: 11135-9. PMID 7479952 DOI: 10.1073/Pnas.92.24.11135  0.491
1994 Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 18: S136-41. PMID 8148441 DOI: 10.1093/Clinids/18.Supplement_1.S136  0.308
1994 Koito A, Harrowe G, Levy JA, Cheng-Mayer C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. Journal of Virology. 68: 2253-9. PMID 8139010 DOI: 10.1128/Jvi.68.4.2253-2259.1994  0.495
1994 Sawai ET, Baur A, Struble H, Peterlin BM, Levy JA, Cheng-Mayer C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 91: 1539-43. PMID 8108442 DOI: 10.1073/Pnas.91.4.1539  0.407
1994 Dumitrescu O, Kalish ML, Kliks SC, Bandea CI, Levy JA. Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. The Journal of Infectious Diseases. 169: 281-8. PMID 8106761 DOI: 10.1093/Infdis/169.2.281  0.518
1994 Kliks SC, Wara DW, Landers DV, Levy JA. Features of HIV-1 that could influence maternal-child transmission. Jama. 272: 467-74. PMID 8040983 DOI: 10.1001/Jama.1994.03520060067034  0.518
1994 Ichimura H, Kliks SC, Visrutaratna S, Ou CY, Kalish ML, Levy JA. Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. Aids Research and Human Retroviruses. 10: 263-9. PMID 8018386 DOI: 10.1089/Aid.1994.10.263  0.464
1994 Mackewicz CE, Yang LC, Lifson JD, Levy JA. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet (London, England). 344: 1671-3. PMID 7996961 DOI: 10.1016/S0140-6736(94)90459-6  0.569
1994 Hsueh FW, Walker CM, Blackbourn DJ, Levy JA. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cellular Immunology. 159: 271-9. PMID 7994759 DOI: 10.1006/Cimm.1994.1313  0.566
1994 Poulin L, Fauchon M, Darveau A, Levy JA. Inhibition of protein synthesis by the human immunodeficiency virus type 1 nef gene product. The Journal of General Virology. 75: 2977-84. PMID 7964607 DOI: 10.1099/0022-1317-75-11-2977  0.396
1994 Barnett SW, Murthy KK, Herndier BG, Levy JA. An AIDS-like condition induced in baboons by HIV-2. Science (New York, N.Y.). 266: 642-6. PMID 7939718 DOI: 10.1126/Science.7939718  0.549
1994 Levy JA. Long-term survivors of HIV infection. Hospital Practice (Office Ed.). 29: 41-4, 47, 51-2. PMID 7929674 DOI: 10.1080/21548331.1994.11443088  0.553
1994 Mackewicz CE, Landay A, Hollander H, Levy JA. Effect of zidovudine therapy on CD8+ T cell anti-HIV activity. Clinical Immunology and Immunopathology. 73: 80-7. PMID 7923920 DOI: 10.1006/Clin.1994.1172  0.46
1994 Kliks SC, Levy JA. Maternal antibody response and maternal-infant HIV-1 transmission. Lancet (London, England). 343: 1364. PMID 7910354 DOI: 10.1016/S0140-6736(94)92501-1  0.369
1994 Mackewicz CE, Ortega H, Levy JA. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cellular Immunology. 153: 329-43. PMID 7907003 DOI: 10.1006/Cimm.1994.1032  0.495
1994 Stamatatos L, Levy JA. CD26 is not involved in infection of peripheral blood mononuclear cells by HIV-1. Aids (London, England). 8: 1727-8. PMID 7888123  0.399
1994 Blackbourn DJ, Mackewicz C, Barker E, Levy JA. Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine. Research in Immunology. 145: 653-8; discussion 65. PMID 7754216 DOI: 10.1016/S0923-2494(05)80049-5  0.475
1994 Herndier BG, Werner A, Arnstein P, Abbey NW, Demartis F, Cohen RL, Shuman MA, Levy JA. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. Aids (London, England). 8: 575-81. PMID 7520247 DOI: 10.1097/00002030-199405000-00002  0.38
1994 Eaton AM, Ugen KE, Weiner DB, Wildes T, Levy JA. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. Aids Research and Human Retroviruses. 10: 13-8. PMID 7514015 DOI: 10.1089/Aid.1994.10.13  0.531
1994 Pan LZ, Levy JA. Inhibition of HIV replication by trichosanthin in peripheral blood mononuclear cells Current Therapeutic Research. 55: 718-727. DOI: 10.1016/S0011-393X(05)80807-0  0.535
1993 Levy JA. HIV and host immune responses in AIDS pathogenesis. Journal of Clinical Apheresis. 8: 19-28. PMID 8505278 DOI: 10.1002/Jca.2920080106  0.434
1993 Werner A, Levy JA. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. Journal of Virology. 67: 2566-74. PMID 8474162 DOI: 10.1128/Jvi.67.5.2566-2574.1993  0.544
1993 Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiological Reviews. 57: 183-289. PMID 8464405 DOI: 10.1128/Mmbr.57.1.183-289.1993  0.59
1993 Levy JA. Features of human immunodeficiency virus infection and disease. Pediatric Research. 33: S63-9; discussion S6. PMID 8433877 DOI: 10.1203/00006450-199333011-00012  0.544
1993 Barnett SW, Quiroga M, Werner A, Dina D, Levy JA. Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. Journal of Virology. 67: 1006-14. PMID 8419635 DOI: 10.1128/Jvi.67.2.1006-1014.1993  0.525
1993 Landay AL, Mackewicz CE, Levy JA. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology and Immunopathology. 69: 106-16. PMID 8403538 DOI: 10.1006/Clin.1993.1157  0.441
1993 Levy JA. The transmission of HIV and factors influencing progression to AIDS. The American Journal of Medicine. 95: 86-100. PMID 8328502 DOI: 10.1016/0002-9343(93)90237-J  0.567
1993 Levy JA. HIV pathogenesis and long-term survival. Aids (London, England). 7: 1401-10. PMID 8280406 DOI: 10.1097/00002030-199311000-00001  0.403
1993 Mosier DE, Gulizia RJ, MacIsaac PD, Torbett BE, Levy JA. Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science (New York, N.Y.). 260: 689-92. PMID 8097595 DOI: 10.1126/Science.8097595  0.537
1993 Pan LZ, Werner A, Levy JA. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. Journal of Clinical Microbiology. 31: 283-8. PMID 8094395 DOI: 10.1128/Jcm.31.2.283-288.1993  0.503
1993 Kliks SC, Shioda T, Haigwood NL, Levy JA. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 90: 11518-22. PMID 7505441 DOI: 10.1073/Pnas.90.24.11518  0.357
1992 Tang S, Poulin L, Levy JA. Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication. The Journal of General Virology. 73: 933-9. PMID 1634879 DOI: 10.1099/0022-1317-73-4-933  0.548
1992 Berger JR, Levy JA. The human immunodeficiency virus, type 1: the virus and its role in neurologic disease. Seminars in Neurology. 12: 1-9. PMID 1615234 DOI: 10.1055/S-2008-1041151  0.41
1992 Barboza A, Castro BA, Whalen M, Moore CC, Parkin JS, Miller WL, Gonzalez-Scarano F, Levy JA. Infection of cultured human adrenal cells by different strains of HIV. Aids (London, England). 6: 1437-43. PMID 1492929 DOI: 10.1097/00002030-199212000-00003  0.522
1992 Poulin L, Levy JA. The HIV-1 nef gene product is associated with phosphorylation of a 46 kD cellular protein. Aids (London, England). 6: 787-91. PMID 1418774 DOI: 10.1097/00002030-199208000-00003  0.425
1992 Shioda T, Levy JA, Cheng-Mayer C. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 89: 9434-8. PMID 1409653 DOI: 10.1073/Pnas.89.20.9434  0.46
1992 Mackewicz C, Levy JA. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. Aids Research and Human Retroviruses. 8: 1039-50. PMID 1354466 DOI: 10.1089/Aid.1992.8.1039  0.534
1992 Le Guern M, Levy JA. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range. Proceedings of the National Academy of Sciences of the United States of America. 89: 363-7. PMID 1346069 DOI: 10.1073/Pnas.89.1.363  0.573
1992 Castro BA, Homsy J, Lennette E, Murthy KK, Eichberg JW, Levy JA. HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. Clinical Immunology and Immunopathology. 65: 227-33. PMID 1333378 DOI: 10.1016/0090-1229(92)90151-D  0.538
1991 Brown M, Reed S, Levy JA, Busch M, McKerrow JH. Detection of HIV-1 in Entamoeba histolytica without evidence of transmission to human cells. Aids (London, England). 5: 93-6. PMID 2059366 DOI: 10.1097/00002030-199101000-00014  0.529
1991 Barnett SW, Barboza A, Wilcox CM, Forsmark CE, Levy JA. Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. Virology. 182: 802-9. PMID 2024498 DOI: 10.1016/0042-6822(91)90621-H  0.449
1991 Cheng-Mayer C, Seto D, Levy JA. Altered host range of HIV-1 after passage through various human cell types. Virology. 181: 288-94. PMID 1994578 DOI: 10.1016/0042-6822(91)90494-V  0.516
1991 Shioda T, Levy JA, Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature. 349: 167-9. PMID 1986308 DOI: 10.1038/349167A0  0.554
1991 Pan LZ, Sheppard HW, Winkelstein W, Levy JA. Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection. The Journal of Infectious Diseases. 164: 962-4. PMID 1940475 DOI: 10.1093/Infdis/164.5.962  0.481
1991 Walker CM, Erickson AL, Hsueh FC, Levy JA. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. Journal of Virology. 65: 5921-7. PMID 1920621 DOI: 10.1128/Jvi.65.11.5921-5927.1991  0.52
1991 Weintrub PS, Ulrich PP, Edwards JR, Boucher F, Levy JA, Cowan MJ, Vyas GN. Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women. Aids (London, England). 5: 881-4. PMID 1892594 DOI: 10.1097/00002030-199107000-00014  0.443
1991 Rowley AH, Castro B, Levy J, Sullivan J, Koup R, Fresco R, Shulman ST. Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki syndrome. Pediatric Research. 29: 417-419. PMID 1716754 DOI: 10.1203/00006450-199105010-00001  0.306
1991 Poulin L, Evans LA, Tang SB, Barboza A, Legg H, Littman DR, Levy JA. Several CD4 domains can play a role in human immunodeficiency virus infection in cells. Journal of Virology. 65: 4893-901. PMID 1714523 DOI: 10.1128/Jvi.65.9.4893-4901.1991  0.474
1991 Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. The Journal of Clinical Investigation. 87: 1462-6. PMID 1707063 DOI: 10.1172/Jci115153  0.482
1991 Martin NL, Levy JA, Legg H, Weintrub PS, Cowan MJ, Wara DW. Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins. The Journal of Pediatrics. 118: 354-8. PMID 1705583 DOI: 10.1016/S0022-3476(05)82146-8  0.496
1991 Levy JA. Viral and cellular factors influencing HIV tropism. Advances in Experimental Medicine and Biology. 300: 1-15. PMID 1685854 DOI: 10.1007/978-1-4684-5976-0_1  0.589
1991 Tang SB, Levy JA. Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells. Journal of Virological Methods. 33: 39-46. PMID 1682337 DOI: 10.1016/0166-0934(91)90005-K  0.571
1991 Walker CM, Thomson-Honnebier GA, Hsueh FC, Erickson AL, Pan LZ, Levy JA. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular Immunology. 137: 420-8. PMID 1680028 DOI: 10.1016/0008-8749(91)90090-X  0.576
1991 Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet (London, England). 338: 707-12. PMID 1679864 DOI: 10.1016/0140-6736(91)91440-6  0.344
1991 Castro BA, Nepomuceno M, Lerche NW, Eichberg JW, Levy JA. Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Virology. 184: 219-26. PMID 1678564 DOI: 10.1016/0042-6822(91)90838-3  0.573
1991 Castro BA, Walker CM, Eichberg JW, Levy JA. Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. Cellular Immunology. 132: 246-55. PMID 1676614 DOI: 10.1016/0008-8749(91)90023-5  0.548
1991 Cheng-Mayer C, Shioda T, Levy JA. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. Journal of Virology. 65: 6931-41. PMID 1658383 DOI: 10.1128/Jvi.65.12.6931-6941.1991  0.525
1991 LEVY JA. HIV Research and nef Allelles Science. 253: 366-366. DOI: 10.1126/Science.253.5018.366-A  0.429
1990 Cheng-Mayer C, Quiroga M, Tung JW, Dina D, Levy JA. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. Journal of Virology. 64: 4390-8. PMID 2384920 DOI: 10.1128/Jvi.64.9.4390-4398.1990  0.556
1990 York-Higgins D, Cheng-Mayer C, Bauer D, Levy JA, Dina D. Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. Journal of Virology. 64: 4016-20. PMID 2370688 DOI: 10.1128/Jvi.64.8.4016-4020.1990  0.486
1990 Homsy J, Meyer M, Levy JA. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals. Journal of Virology. 64: 1437-40. PMID 2319642 DOI: 10.1128/Jvi.64.4.1437-1440.1990  0.559
1990 Liu ZQ, Wood C, Levy JA, Cheng-Mayer C. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. Journal of Virology. 64: 6148-53. PMID 2243391 DOI: 10.1128/Jvi.64.12.6148-6153.1990  0.516
1990 Weiss CD, Levy JA, White JM. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. Journal of Virology. 64: 5674-7. PMID 2214033 DOI: 10.1128/Jvi.64.11.5674-5677.1990  0.339
1990 Tang SB, Levy JA. Parameters involved in the cell fusion induced by HIV. Aids (London, England). 4: 409-15. PMID 2196907 DOI: 10.1097/00002030-199005000-00005  0.482
1990 Cheng-Mayer C, Levy JA. Human immunodeficiency virus infection of the CNS: characterization of "neurotropic" strains. Current Topics in Microbiology and Immunology. 160: 145-56. PMID 2191840 DOI: 10.1007/978-3-642-75267-4_9  0.342
1990 Levy JA, Landay A, Lennette ET. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. Journal of Clinical Microbiology. 28: 2362-4. PMID 2172289 DOI: 10.1128/Jcm.28.10.2362-2364.1990  0.574
1990 Canivet M, Hoffman AD, Hardy D, Sernatinger J, Levy JA. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. Virology. 178: 543-51. PMID 2171193 DOI: 10.1016/0042-6822(90)90352-R  0.582
1990 Levy JA. The pathogenesis of HIV infection. Hospital Practice (Office Ed.). 25: 41-8. PMID 2146279 DOI: 10.1080/21548331.1990.11704032  0.53
1990 Castro BA, Barnett SW, Evans LA, Moreau J, Odehouri K, Levy JA. Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains. Virology. 178: 527-34. PMID 2120848 DOI: 10.1016/0042-6822(90)90350-Z  0.533
1990 Levy JA. Changing concepts in HIV infection: challenges for the 1990s. Aids (London, England). 4: 1051-8. PMID 1980820 DOI: 10.1097/00002030-199011000-00001  0.481
1990 Levy JA, Ferro F, Lennette ET, Oshiro L, Poulin L. Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual. Virology. 178: 113-21. PMID 1975142 DOI: 10.1016/0042-6822(90)90384-4  0.48
1990 Wiviott LD, Walker CM, Levy JA. CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cellular Immunology. 128: 628-34. PMID 1972661 DOI: 10.1016/0008-8749(90)90054-U  0.519
1990 Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet (London, England). 335: 1047-50. PMID 1970369 DOI: 10.1016/0140-6736(90)92628-U  0.474
1990 Yong WH, Wyman S, Levy JA. Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction. Aids (London, England). 4: 199-206. PMID 1693515 DOI: 10.1097/00002030-199003000-00004  0.374
1989 Cheng-Mayer C, Weiss C, Seto D, Levy JA. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proceedings of the National Academy of Sciences of the United States of America. 86: 8575-9. PMID 2813413 DOI: 10.1073/Pnas.86.21.8575  0.499
1989 Homsy J, Meyer M, Tateno M, Clarkson S, Levy JA. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science (New York, N.Y.). 244: 1357-60. PMID 2786647 DOI: 10.1126/Science.2786647  0.523
1989 Tateno M, Gonzalez-Scarano F, Levy JA. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 4287-90. PMID 2786212 DOI: 10.1073/Pnas.86.11.4287  0.565
1989 Edwards JR, Ulrich PP, Weintrub PS, Cowan MJ, Levy JA, Wara DW, Vyas GN. Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. The Journal of Pediatrics. 115: 200-3. PMID 2754549 DOI: 10.1016/S0022-3476(89)80065-4  0.465
1989 Levy JA, Margaretten W, Nelson J. Detection of HIV in enterochromaffin cells in the rectal mucosa of an AIDS patient. The American Journal of Gastroenterology. 84: 787-9. PMID 2741889 DOI: 10.1111/J.1572-0241.1989.Tb02653.X  0.561
1989 Morrow WJ, Homsy J, Eichberg JW, Krowka J, Pan LZ, Gaston I, Legg H, Lerche N, Thomas J, Levy JA. Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment. Aids Research and Human Retroviruses. 5: 233-45. PMID 2713168 DOI: 10.1089/Aid.1989.5.233  0.555
1989 Evans LA, Levy JA. Characteristics of HIV infection and pathogenesis. Biochimica Et Biophysica Acta. 989: 237-54. PMID 2695168  0.406
1989 Levy JA. Human immunodeficiency viruses and the pathogenesis of AIDS. Jama. 261: 2997-3006. PMID 2654428 DOI: 10.1001/Jama.1989.03420200087044  0.546
1989 Levy JA. Pathogenesis of human immunodeficiency virus infection Annals of the New York Academy of Sciences. 567: 58-68. PMID 2552893 DOI: 10.1111/J.1749-6632.1989.Tb16459.X  0.457
1989 Evans LA, Thomson-Honnebier G, Steimer K, Paoletti E, Perkus ME, Hollander H, Levy JA. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. Aids (London, England). 3: 273-6. PMID 2548535 DOI: 10.1097/00002030-198905000-00004  0.475
1989 Greenspan D, Greenspan JS, de Souza Y, Levy JA, Ungar AM. Oral hairy leukoplakia in an HIV-negative renal transplant recipient. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 18: 32-4. PMID 2545870 DOI: 10.1111/J.1600-0714.1989.Tb00729.X  0.426
1989 Cheng-Mayer C, Iannello P, Shaw K, Luciw PA, Levy JA. Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science (New York, N.Y.). 246: 1629-32. PMID 2531920 DOI: 10.1126/Science.2531920  0.542
1989 Schiødt M, Greenspan D, Levy JA, Nelson JA, Chernoff D, Hollander H, Greenspan JS. Does HIV cause salivary gland disease? Aids (London, England). 3: 819-22. PMID 2517203 DOI: 10.1097/00002030-198912000-00006  0.493
1989 Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cellular Immunology. 119: 470-5. PMID 2495184 DOI: 10.1016/0008-8749(89)90259-1  0.483
1989 Michaelis B, Levy JA. HIV replication can be blocked by recombinant human interferon beta Aids. 3: 27-31. DOI: 10.1097/00002030-198901000-00006  0.431
1988 Dean NC, Golden JA, Evans LA, Warnock ML, Addison TE, Hopewell PC, Levy JA. Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS. Chest. 93: 1176-9. PMID 3371096 DOI: 10.1378/Chest.93.6.1176  0.498
1988 Cheng-Mayer C, Homsy J, Evans LA, Levy JA. Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization. Proceedings of the National Academy of Sciences of the United States of America. 85: 2815-9. PMID 3357892 DOI: 10.1073/Pnas.85.8.2815  0.524
1988 Levy JA. Mysteries of HIV: challenges for therapy and prevention Nature. 333: 519-522. PMID 3287174 DOI: 10.1038/333519A0  0.433
1988 Levy JA. The Transmission of AIDS: The Case of the Infected Cell Jama: the Journal of the American Medical Association. 259: 3037-3038. PMID 3285042 DOI: 10.1001/Jama.1988.03720200059035  0.575
1988 Homsy J, Thomson-Honnebier GA, Cheng-Mayer C, Levy JA. Detection of human immunodeficiency virus (HIV) in serum and body fluids by sequential competition ELISA. Journal of Virological Methods. 19: 43-56. PMID 3280585 DOI: 10.1016/0166-0934(88)90006-7  0.492
1988 Castro BA, Weiss CD, Wiviott LD, Levy JA. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells Journal of Clinical Microbiology. 26: 2371-2376. PMID 3266220 DOI: 10.1128/Jcm.26.11.2371-2376.1988  0.452
1988 Tateno M, Levy JA. MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV) Virology. 167: 299-301. PMID 3263731 DOI: 10.1016/0042-6822(88)90084-0  0.534
1988 Cheng-Mayer C, Levy JA. Distinct biological and serological properties of human immunodeficiency viruses from the brain Annals of Neurology. 23. PMID 3258140 DOI: 10.1002/Ana.410230716  0.365
1988 Winkelstein W, Wiley JA, Padian NS, Samuel M, Shiboski S, Ascher MS, Levy JA. The San Francisco Men's Health Study: continued decline in HIV seroconversion rates among homosexual/bisexual men. American Journal of Public Health. 78: 1472-4. PMID 3177723 DOI: 10.2105/Ajph.78.11.1472  0.483
1988 Cowan MJ, Walker C, Culver K, Weintrub PS, Wara DW, Levy JA. Maternally transmitted HIV infection in children Aids. 2: 437-441. PMID 3149491 DOI: 10.1097/00002030-198812000-00005  0.515
1988 Castro BA, Cheng-Mayer C, Evans LA, Levy JA. HIV heterogeneity and viral pathogenesis. Aids (London, England). 2: S17-27. PMID 3147667 DOI: 10.1097/00002030-198800001-00004  0.562
1988 Evans LA, Moreau J, Odehouri K, Seto D, Thomson-Honnebier G, Legg H, Barboza A, Cheng-Mayer C, Levy JA. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet (London, England). 2: 1389-91. PMID 2904524 DOI: 10.1016/S0140-6736(88)90586-7  0.55
1988 Levy J, Greenspan D. Hiv In Saliva The Lancet. 332: 1248. PMID 2903974 DOI: 10.1016/S0140-6736(88)90835-5  0.47
1988 Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, Levy JA. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet. 1: 259-62. PMID 2893081 DOI: 10.1016/S0140-6736(88)90348-0  0.556
1988 Walker CM, Steimer KS, Rosenthal KL, Levy JA. Identification of human immunodeficiency virus (HIV) envelope type-specific T helper cells in an HIV-infected individual Journal of Clinical Investigation. 82: 2172-2175. PMID 2848870 DOI: 10.1172/Jci113841  0.536
1988 Sernatinger J, Hoffman A, Hardman D, Kane JP, Levy JA. Neutralization of mouse xenotropic virus by lipoproteins involves binding to the virions. The Journal of General Virology. 2657-61. PMID 2844973 DOI: 10.1099/0022-1317-69-10-2657  0.35
1988 Evans LA, Moreau J, Odehouri K, Legg H, Barboza A, Cheng-Mayer C, Levy JA. Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science (New York, N.Y.). 240: 1522-5. PMID 2836951 DOI: 10.1126/Science.2836951  0.554
1988 Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 that correlate with virulence in the host. Science (New York, N.Y.). 240: 80-2. PMID 2832945 DOI: 10.1126/Science.2832945  0.556
1988 Gras G, Strub T, Dormont D, Homsy J, Tateno M, Levy J. Antibody-Dependent Enhancement Of Hiv Infection The Lancet. 331: 1285-1286. DOI: 10.1016/S0140-6736(88)92106-X  0.496
1987 Winkelstein W, Samuel M, Padian NS, Wiley JA, Lang W, Anderson RE, Levy JA. The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. American Journal of Public Health. 77: 685-9. PMID 3646848 DOI: 10.2105/Ajph.77.6.685  0.445
1987 Hollander H, Levy JA. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid Annals of Internal Medicine. 106: 692-695. PMID 3646001 DOI: 10.7326/0003-4819-106-5-692  0.502
1987 Michaelis BA, Levy JA. Recovery of Human Immunodeficiency Virus From Serum Jama: the Journal of the American Medical Association. 257: 1327. PMID 3644021 DOI: 10.1001/Jama.1987.03390100065011  0.449
1987 Kaplan LD, Wolfe PR, Volberding PA, Feorino P, Abrams DI, Levy JA, Wong R, Kaufman L, Gottlieb MS. Lack of response to suramin in patients with AIDS and AIDS-related complex The American Journal of Medicine. 82: 615-620. PMID 3548350 DOI: 10.1016/0002-9343(87)90108-2  0.437
1987 Pan LZ, Cheng-Mayer C, Levy JA. Patterns of antibody response in individuals infected with the human immunodeficiency virus. The Journal of Infectious Diseases. 155: 626-32. PMID 3546516 DOI: 10.1093/Infdis/155.4.626  0.418
1987 Levy JA. Indirect Immunofluorescence Assays Can Readily Detect Antibodies to the Human Immunodeficiency Virus Jama: the Journal of the American Medical Association. 257: 1176. PMID 3543424 DOI: 10.1001/Jama.1987.03390090048013  0.432
1987 Eichberg JW, Zarling JM, Alter HJ, Levy JA, Berman PW, Gregory T, Lasky LA, McClure J, Cobb KE, Moran PA. T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. Journal of Virology. 61: 3804-8. PMID 3500328 DOI: 10.1128/Jvi.61.12.3804-3808.1987  0.561
1987 Greenspan D, Greenspan JS, Hearst NG, Pan LZ, Conant MA, Abrams DI, Hollander H, Levy JA. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. The Journal of Infectious Diseases. 155: 475-81. PMID 3492574 DOI: 10.1093/Infdis/155.3.475  0.516
1987 Cheng-Mayer C, Rutka JT, Rosenblum ML, McHugh T, Stites DP, Levy JA. Human immunodeficiency virus can productively infect cultured human glial cells. Proceedings of the National Academy of Sciences of the United States of America. 84: 3526-30. PMID 3472222 DOI: 10.1073/Pnas.84.10.3526  0.529
1987 Gerberding JL, Bryant-LeBlanc CE, Nelson K, Moss AR, Osmond D, Chambers HF, Carlson JR, Drew WL, Levy JA, Sande MA. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. The Journal of Infectious Diseases. 156: 1-8. PMID 3036953 DOI: 10.1016/S0022-5347(17)43720-7  0.384
1987 Stricker RB, McHugh TM, Moody DJ, Morrow WJ, Stites DP, Shuman MA, Levy JA. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature. 327: 710-3. PMID 2955226 DOI: 10.1038/327710A0  0.465
1987 Morrow WJ, Wharton M, Lau D, Levy JA. Small animals are not susceptible to human immunodeficiency virus infection. The Journal of General Virology. 2253-7. PMID 2886549 DOI: 10.1099/0022-1317-68-8-2253  0.519
1987 Hoffman AD, Levy JA. Mouse xenotropic viruses can inhibit cell transformation Virology. 160: 60-65. PMID 2820140 DOI: 10.1016/0042-6822(87)90044-4  0.351
1987 Luciw PA, Cheng-Mayer C, Levy JA. Mutational analysis of the human immunodeficiency virus: The orf-B region down-regulates virus replication Proceedings of the National Academy of Sciences of the United States of America. 84: 1434-1438. PMID 2434956 DOI: 10.1073/Pnas.84.5.1434  0.469
1987 Perkins H, Samson S, Garner J, Echenberg D, Allen J, Cowan M, Levy J. Risk of AIDS for recipients of blood components from donors who subsequently developed AIDS Blood. 70: 1604-1610. DOI: 10.1182/Blood.V70.5.1604.1604  0.452
1987 Eichberg JW, Zarling JM, Alter HJ, Levy JA, Berman PW, Gregory T, Lasky LA, McClure J, Cobb KE, Moran PA. T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. Journal of Virology. 61: 3804-3808. DOI: 10.1128/jvi.61.12.3804-3808.1987  0.486
1987 Lennette ET, Karpatkin S, Levy JA. Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. Journal of Clinical Microbiology. 25: 199-202. DOI: 10.1128/Jcm.25.2.199-202.1987  0.45
1987 Koenig RE, Brache LG, Levy JA. HIV Infection in the Dominican Republic-Reply Jama: the Journal of the American Medical Association. 258: 47-47. DOI: 10.1001/Jama.1987.03400010050025  0.425
1987 Lang W, Anderson RE, Perkins H, Grant RM, Lyman D, Winkelstein W, Royce R, Levy JA. Clinical, Immunologic, and Serologic Findings in Men at Risk for Acquired Immunodeficiency Syndrome: The San Francisco Men’s Health Study Jama: the Journal of the American Medical Association. 257: 326-330. DOI: 10.1001/Jama.1987.03390030056020  0.44
1986 Morrow WJ, Wharton M, Stricker RB, Levy JA. Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clinical Immunology and Immunopathology. 40: 515-24. PMID 3731542 DOI: 10.1016/0090-1229(86)90196-0  0.316
1986 Moss A, Osmond D, Bacchetti P, Gerberding J, Levy J, Carlson J, Casavant C. Risk of seroconversion for acquired immunodeficiency syndrome (AIDS) in San Francisco health workers. Journal of Occupational and Environmental Medicine. 28: 821-824. PMID 3534165 DOI: 10.1097/00043764-198609000-00013  0.406
1986 Levy JA, Pan LZ, Beth-Giraldo E, Kaminsky LS, Henle G, Henle W, Giraldo G. Absence of antibodies to the human immunodeficiency virus in sera from Africa prior to 1975. Proceedings of the National Academy of Sciences of the United States of America. 83: 7935-7. PMID 3464008 DOI: 10.1073/Pnas.83.20.7935  0.652
1986 Mitra G, Wong MF, Mozen MM, McDougal JS, Levy JA. Elimination of infectious retroviruses during preparation of immunoglobulins. Transfusion. 26: 394-7. PMID 3014692 DOI: 10.1046/J.1537-2995.1986.26486262753.X  0.357
1986 Ammann AJ, Levy J. Laboratory investigation of pediatric acquired immunodeficiency syndrome. Clinical Immunology and Immunopathology. 40: 122-127. PMID 3013472 DOI: 10.1016/0090-1229(86)90075-9  0.384
1986 Banapour B, Sernatinger J, Levy JA. The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum Virology. 152: 268-271. PMID 3012872 DOI: 10.1016/0042-6822(86)90392-2  0.37
1986 Levy JA, Chen-Mayer C, Dina D, Luciw PA. AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts Science. 232: 998-1001. PMID 3010461 DOI: 10.1126/Science.3010461  0.446
1986 Coffin J, Haase A, Levy JA, Montagnier L, Oroszlan S, Teich N, Temin H, Toyoshima K, Varmus H, Vogt P. What to call the AIDS virus? Nature. 321: 10. PMID 3010128 DOI: 10.1038/321010a0  0.324
1986 Coffin J, Haase A, Levy JA, Montagnier L, Oroszlan S, Teich N, Temin H, Toyoshima K, Varmus H, Vogt P, Weiss R. Human immunodeficiency viruses [1] Science. 232: 697. PMID 3008335 DOI: 10.1126/Science.3008335  0.542
1986 Steimer KS, Puma JP, Power MD, Powers MA, George-Nascimento C, Stephans JC, Levy JA, Sanchez-Pescador R, Luciw PA, Barr PJ, Hallewell RA. Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria Virology. 150: 283-290. PMID 3006341 DOI: 10.1016/0042-6822(86)90289-8  0.442
1986 Koenig RE, Gautier T, Levy J. Unusual Intrafamilial Transmission Of Human Immunodeficiency Virus The Lancet. 328: 627. PMID 2875337 DOI: 10.1016/S0140-6736(86)92448-7  0.424
1986 Wofsy CB, Cohen JB, Hauer LB, Padian NS, Michaelis BA, Evans LA, Levy JA. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet. 1: 527-9. PMID 2869262 DOI: 10.1016/S0140-6736(86)90885-8  0.406
1986 Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science (New York, N.Y.). 234: 1563-6. PMID 2431484 DOI: 10.1126/Science.2431484  0.563
1986 Levy JA, Shimabukuro J, McHugh T, Casavant C, Stites D, Oshiro L. AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. Virology. 147: 441-8. PMID 2416120 DOI: 10.1016/0042-6822(85)90146-1  0.455
1986 Ragni M, Tegtmeier G, Levy J, Kaminsky L, Lewis J, Spero J, Bontempo F, Handwerk-Leber C, Bayer W, Zimmerman D. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations Blood. 67: 592-595. DOI: 10.1182/Blood.V67.3.592.Bloodjournal673592  0.362
1986 Conant M, Spicer D, Levy JA. Condoms Prevent Transmission of AIDS-Associated Retrovirus Jama: the Journal of the American Medical Association. 255: 1706-1706. DOI: 10.1001/Jama.1986.03370130062013  0.358
1986 Lyman D, Winkelstein W, Ascher M, Levy JA. Minimal Risk of Transmission of AIDS-Associated Retrovirus Infection by Oral-Genital Contact Jama: the Journal of the American Medical Association. 255: 1703-1703. DOI: 10.1001/Jama.1986.03370130059009  0.308
1986 Coleman DL, Luce JM, Wilber JC, Ferrer JJ, Stephens BG, Margaretten W, Wagar EA, Hadley WK, Pifer LL, Moss AR, Dodek PM, Levy JA, Murray JF. Antibody to the Retrovirus Associated With the Acquired Immunodeficiency Syndrome (AIDS): Presence in Presumably Healthy San Franciscans Who Died Unexpectedly Archives of Internal Medicine. 146: 713-715. DOI: 10.1001/Archinte.1986.00360160137018  0.312
1985 Levy JA, Tobler LH, McHugh TM, Casavant CH, Stites DP. Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome. Clinical Immunology and Immunopathology. 35: 328-36. PMID 3157520 DOI: 10.1016/0090-1229(85)90093-5  0.321
1985 Levy JA, Kaminsky LS, Morrow WJW, Steimer K, Luciw P, Dina D, Hoxie J, Oshiro L. Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features Annals of Internal Medicine. 103: 694-699. PMID 2996401 DOI: 10.1016/S0022-5347(17)44958-5  0.477
1985 Hoxie JA, Haggarty BS, Rackowski JL, Pillsbury N, Levy JA. Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus Science. 229: 1400-1402. PMID 2994222 DOI: 10.1126/Science.2994222  0.464
1985 Kaminsky LS, McHugh T, Stites D, Volberding P, Henle G, Henle W, Levy JA. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proceedings of the National Academy of Sciences of the United States of America. 82: 5535-9. PMID 2991932 DOI: 10.1073/Pnas.82.16.5535  0.595
1985 Thiry L, Sprecher-Goldberger S, Jonckheer T, Levy J, Van de Perre P, Henrivaux P, Cogniaux-LeClerc J, Clumeck N. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet (London, England). 2: 891-2. PMID 2864603 DOI: 10.1016/S0140-6736(85)90156-4  0.348
1985 Koerper M, Kaminsky L, Levy J. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus. The Lancet. 325: 275. PMID 2857339 DOI: 10.1016/S0140-6736(85)91049-9  0.368
1985 Sanchez-Pescador R, Power MD, Barr PJ, Steimer KS, Stempien MM, Brown-Shimer SL, Gee WW, Renard A, Randolph A, Levy JA. Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). Science (New York, N.Y.). 227: 484-92. PMID 2578227 DOI: 10.1126/Science.2578227  0.343
1985 Morrow WJW, Levy JA. The viral etiology of AIDS Clinical Immunology Newsletter. 6: 113-116. DOI: 10.1016/S0197-1859(85)80030-3  0.338
1985 Levy J, Hollander H, Shimabukuro J, Mills J, Kaminsky L. Isolation Of Aids-Associated Retroviruses From Cerebrospinal Fluid And Brain Of Patients With Neurological Symptoms The Lancet. 326: 585-588. DOI: 10.1016/S0140-6736(85)90587-2  0.388
1984 Varnier OE, Hoffman AD, Nexø BA, Levy JA. Murine xenotropic type C viruses. V. Biologic and structural differences among three cloned retroviruses isolated from kidney cells from one NZB mouse. Virology. 132: 79-94. PMID 6607566 DOI: 10.1016/0042-6822(84)90093-X  0.419
1984 Leong JC, Nelson JA, Levy JA. Optimal conditions for detection of reverse transcriptase activity in human placentas Bba - Gene Structure and Expression. 782: 441-445. PMID 6206894 DOI: 10.1016/0167-4781(84)90052-6  0.327
1984 Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (New York, N.Y.). 225: 840-2. PMID 6206563 DOI: 10.1126/Science.6206563  0.389
1984 Leong JC, Wood SO, Lyford AO, Levy JA. Purification of a specific inhibitor of reverse transcriptase from human placenta International Journal of Cancer. 33: 435-439. PMID 6200446 DOI: 10.1002/Ijc.2910330403  0.319
1984 Luciw PA, Potter SJ, Steimer K, Dina D, Levy JA. Molecular cloning of AIDS-associated retrovirus Nature. 312: 760-763. PMID 6096718 DOI: 10.1038/312760A0  0.448
1984 Hays EF, Levy JA. Differences in lymphomagenic properties of AKR mouse retroviruses Virology. 138: 49-57. PMID 6093361 DOI: 10.1016/0042-6822(84)90146-6  0.353
1984 Hill AB, May W, Kaminsky LS, Levy JA, Penny R, Cooper DA. AIDS and related conditions: One year's experience in St Vincent's Hospital, Sydney Medical Journal of Australia. 141: 573-578. DOI: 10.5694/J.1326-5377.1984.Tb113140.X  0.311
1983 Putman DL, Nayar KT, O'Neill B, Premkumar-Reddy E, Levy JA, Kouri RE. Genetics of xenotropic virus expression in mice. II. Expression of major virus structural proteins in crosses involving NZB/B1NJ, SWR/J, and 129/J strains of mice. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 173: 217-21. PMID 6306669 DOI: 10.3181/00379727-173-41634  0.349
1983 Varnier OE, Repetto CM, Raffanti SP, Alama A, Levy JA. Host range differences among xenotropic type C retroviruses isolated from mouse kidney cell cultures. The Journal of General Virology. 425-8. PMID 6300292 DOI: 10.1099/0022-1317-64-2-425  0.387
1983 Levy J. Mouse Plasmacytoma Cells Produce Infectious Type C Viruses The Lancet. 322: 522. PMID 6136684 DOI: 10.1016/S0140-6736(83)90557-3  0.348
1983 Levy JA, Ziegler JL. Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet (London, England). 2: 78-81. PMID 6134963 DOI: 10.1016/S0140-6736(83)90062-4  0.363
1983 Ollero M, Leal M, Wichmann I, Lissen E, Levy JA. Antibodies To The Aids-Associated Retrovirus In Hemophiliacs And Other Individuals From Southern Spain: Lack Of Correlation With Lymphocytes Sub-Populations Aids Research and Human Retroviruses. 1: 439-445. PMID 6100782 DOI: 10.1089/Aid.1.1983.1.439  0.304
1982 Levy JA, Fieldsteel AH. Freeze-drying is an effective method for preserving infectious type C retroviruses Journal of Virological Methods. 5: 165-171. PMID 6296178 DOI: 10.1016/0166-0934(82)90006-4  0.406
1982 Levy JA, Oleszko O, Dimpfl J, Lau D, Rigdon RH, Jones J, Avery R. Murine xenotropic type C viruses. IV. Replication and pathogenesis of ducks. The Journal of General Virology. 65-74. PMID 6288852 DOI: 10.1099/0022-1317-61-1-65  0.396
1982 Levy JA, Jakob H, Paulin D, Kelly F, Chermann JC, Jacob F. Productive infection of embryonal carcinoma cells with ecotropic mouse type C viruses and subsequent arrest of differentiation. Virology. 120: 157-70. PMID 6285595 DOI: 10.1016/0042-6822(82)90014-9  0.398
1982 Levy JA, Dimpfl J, Hardman D, Kane JP. Transfer of mouse anti-xenotropic virus neutralizing factor to human lipoproteins. Journal of Virology. 42: 365-371. DOI: 10.1128/Jvi.42.2.365-371.1982  0.324
1980 Levy JA, Joyner J, Borenfreund E. Mouse sperm can horizontally transmit type C viruses Journal of General Virology. 51: 439-443. PMID 6262445 DOI: 10.1099/0022-1317-51-2-439  0.339
1980 Kane JP, Hardman DA, Dimpfl JC, Levy JA. Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum. Proceedings of the National Academy of Sciences of the United States of America. 76: 5957-61. PMID 230495 DOI: 10.1073/Pnas.76.11.5957  0.313
1979 Levy JA, Rutledge F, Dimpfl J, Silagi S. Recovery of three distinct biologically active type C viruses from cloned C57Bl/6 melanoma cells. The Journal of General Virology. 43: 283-8. PMID 225423 DOI: 10.1099/0022-1317-43-2-283  0.38
1979 Varnier OE, Levy JA. Differential effect of dexamethasone on replication of ecotropic and xenotropic mouse type C viruses Virology. 96: 604-614. PMID 223319 DOI: 10.1016/0042-6822(79)90116-8  0.366
1979 Avery RJ, Levy JA. The effect of ethidium bromide on C type virus production and induction Virology. 95: 277-284. PMID 223282 DOI: 10.1016/0042-6822(79)90483-5  0.401
1979 Levy JA, Joyner J, Nayar KT, Kouri RE. Genetics of xenotropic virus expression in mice. I. Evidence for a single locus regulating spontaneous production of infectious virus in crosses involving NZB/B1NJ and 129/J strains of mice. Journal of Virology. 30: 754-758. DOI: 10.1128/Jvi.30.3.754-758.1979  0.349
1978 Avery RJ, Levy JA. Relationship of endogenous murine xenotropic type C virus production to spontaneous transformation of cultured cells Journal of General Virology. 39: 427-435. PMID 207818 DOI: 10.1099/0022-1317-39-3-427  0.384
1978 Levy JA, Kazan PL, Reilly CA, Finkel MP. FBJ osteosarcoma virus in tissue culture. III. Isolation and characterization of non-virus-producing FBJ-transformed cells Journal of Virology. 26: 11-15. PMID 206718 DOI: 10.1128/Jvi.26.1.11-15.1978  0.377
1978 Levy JA. Xenotropic type C viruses Current Topics in Microbiology and Immunology. 79: 111-213. PMID 77206 DOI: 10.1007/978-3-642-66853-1_4  0.378
1977 Gardner MB, Ihle JN, Pillarisetty RJ, Talal N, Dubois EL, Levy JA. Type C virus expression and host response in diet-cured NZB/W mice. Nature. 268: 341-4. PMID 196213 DOI: 10.1038/268341A0  0.314
1977 Levy JA. Murine xenotropic type C viruses III. Phenotypic mixing with avian leukosis and sarcoma viruses Virology. 77: 811-825. PMID 193265 DOI: 10.1016/0042-6822(77)90501-3  0.441
1977 Levy JA. Murine xenotropic type C viruses II. Phenotypic mixing with mouse and rat ecotropic type C viruses Virology. 77: 797-810. PMID 193264 DOI: 10.1016/0042-6822(77)90500-1  0.416
1977 Hahn BH, Mehta J, Knotts LL, Ihle JN, Levy JA. The effect of altered lymphocyte function on the immunologic disorders of NZB/NZW mice. Response to anti-thymocyte globulin Clinical Immunology and Immunopathology. 8: 225-237. PMID 71225 DOI: 10.1016/0090-1229(77)90112-X  0.313
1977 Oshiro LS, Levy JA, Riggs JL, Lennette EH. Distinction between envelope antigens of murine xenotropic and ecotropic type C viruses by immunoelectron microscopy Journal of General Virology. 35: 317-323. PMID 69013 DOI: 10.1099/0022-1317-35-2-317  0.437
1977 Levy JA, Datta SK, Schwartz RS. Recovery of xenotropic virus but not ecotropic virus during graft-versus-host reaction in mice. Clinical Immunology and Immunopathology. 7: 262-8. PMID 16713 DOI: 10.1016/0090-1229(77)90053-8  0.355
1977 Leong JC, Kane JP, Oleszko O, Levy JA. Antigen specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins Proceedings of the National Academy of Sciences of the United States of America. 74: 276-280. PMID 13366 DOI: 10.1073/Pnas.74.1.276  0.316
1976 Levy JA, Ihle JN, Oleszko O, Barnes RD. Virus-specific neutralization by a soluble non-immunoglobulin factor found naturally in normal mouse sera. Proceedings of the National Academy of Sciences of the United States of America. 72: 5071-5. PMID 174092 DOI: 10.1073/Pnas.72.12.5071  0.404
1976 Levy JA, Levy SB, Levinson W. Inactivation of murine RNA tumor viruses by isatin beta-thiosemicarbazone, its derivatives and analogs. Virology. 74: 426-31. PMID 62447 DOI: 10.1016/0042-6822(76)90348-2  0.338
1975 Levy JA, Hartley JW, Rowe WP, Huebner RJ. Studies of FBJ osteosarcoma virus in tissue culture. II. Autoinhibition of focus formation. Journal of the National Cancer Institute. 54: 615-9. PMID 164561 DOI: 10.1093/Jnci/54.3.615  0.732
1975 Levy JA. Host range of murine xenotropic virus: Replication in avian cells Nature. 253: 140-142. PMID 163009 DOI: 10.1038/253140A0  0.449
1975 Levy JA, Kazan P, Varnier O, Kleiman H. Murine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice. Journal of Virology. 16: 844-853. DOI: 10.1128/Jvi.16.4.844-853.1975  0.437
1974 Levy JA. Autoimmunity and neoplasia. The possible role of c type viruses American Journal of Clinical Pathology. 62: 258-280. PMID 4367272 DOI: 10.1093/Ajcp/62.2.258  0.417
1974 Arnstein P, Levy JA, Oshiro LS, Price PJ, SUk W, Lennette EH. Recovery of Murine Xenotropic Type-C Virus from C57L Mice Journal of the National Cancer Institute. 53: 1787-1792. DOI: 10.1093/Jnci/53.6.1787  0.326
1973 Yuspa SH, Morgan DL, Levy JA. In vitro cultivation of a chemically induced epidermal carcinoma: establishment of three cell lines and isolation of murine leukemia virus. Journal of the National Cancer Institute. 50: 1561-70. PMID 4717567 DOI: 10.1093/Jnci/50.6.1561  0.353
1973 Levy JA, Hartley JW, Rowe WP, Huebner RJ. Studies of FBJ osteosarcoma virus in tissue culture. I. Biologic characteristics of the "C"-type viruses. Journal of the National Cancer Institute. 51: 525-39. PMID 4358136  0.704
1973 Levy JA. Xenotropic viruses: Murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains Science. 182: 1151-1153. PMID 4356281 DOI: 10.1126/Science.182.4117.1151  0.41
1971 Levy JA. Demonstration of differences in murine sarcoma virus foci formed in mouse and rat cells under a soft agar overlay Journal of the National Cancer Institute. 46: 1001-1007. PMID 4333721 DOI: 10.1093/Jnci/46.5.1001  0.405
1971 Levy JA, Rowe WP. Lack of requirement of murine leukemia virus for early steps in infection of mouse embryo cells by murine sarcoma virus. Virology. 45: 844-7. PMID 4331113 DOI: 10.1016/0042-6822(71)90211-X  0.627
1971 Levy JA, Levy SB, Hirshaut Y, Kafuko G, Prince A. Presence of EBV antibodies in sera from wild chimpanzees. Nature. 233: 559-60. PMID 4329824 DOI: 10.1038/233559A0  0.405
1970 Parkman R, Levy JA, Ting RC. Murine sarcoma virus: The question of defectiveness Science. 168: 387-389. PMID 5435899 DOI: 10.1126/Science.168.3929.387  0.425
1970 Levy JA, Pincus T. Demonstration of biological activity of a murine leukemia virus of New Zealand black mice Science. 170: 326-327. PMID 4318971 DOI: 10.1126/Science.170.3955.326  0.413
1970 Levy JA, Huebner RJ. Association of a [corrected] murine leukaemia virus from a mouse lymphoma (2731-L) associated [corrected] with reovirus type 3 infection. Nature. 225: 949-50. PMID 4313576 DOI: 10.1038/225949A0  0.538
1968 Levy JA, Tanabe E, Curnen EC. Occurrence of reovirus antibodies in health African children and in children with Burkitt's lymphoma. Cancer. 21: 53-7. PMID 5634850 DOI: 10.1002/1097-0142(196801)21:1<53::Aid-Cncr2820210109>3.0.Co;2-V  0.593
1968 Levy JA, Henle G, Henle W, Zajac BA. Effect of reovirus type 3 on cultured Burkitt's tumour cells. Nature. 220: 607-8. PMID 4879743 DOI: 10.1038/220607A0  0.55
1968 Levy JA, Huebner RJ, Kern J, Gilden RV. High titre T antigen with minimal amounts of structural antigen in adenovirus-infected cells treated with hydroxyurea. Nature. 217: 744-5. PMID 4295939 DOI: 10.1038/217744A0  0.532
Show low-probability matches.